share and download study presentations
Upload
Log In
Login
Register

Directory

Related presentations

Rugo LBBC metastatic disease 10.2012
Rugo LBBC metastatic disease 10.2012
ASCO 2012: Breast Cancer Updates
ASCO 2012: Breast Cancer Updates
Pertuzumab + Trastuzumab + Docetaxel
Pertuzumab + Trastuzumab + Docetaxel
A Phase Ib/II Trial of Trastuzumab-DM1 (T
A Phase Ib/II Trial of Trastuzumab-DM1 (T
Targeting HER family receptors in breast cancer
Targeting HER family receptors in breast cancer
Responses to Subsequent Anti-HER2 Therapy After Treatment with Positive Metastatic Breast Cancer
Responses to Subsequent Anti-HER2 Therapy After Treatment with Positive Metastatic Breast Cancer
Research To Practice
Research To Practice
Anti HER2 mAbs
Anti HER2 mAbs
Recurrent Head and Neck Cancer: Bevacizumab/Erlotinib
Recurrent Head and Neck Cancer: Bevacizumab/Erlotinib
6 months versus 12 months of adjuvant trastuzumab for patients with
6 months versus 12 months of adjuvant trastuzumab for patients with
New Targeted Agents Demonstrate Greater Efficacy and Tolerability
New Targeted Agents Demonstrate Greater Efficacy and Tolerability

T-DM1 - Research To Practice

Download Report

Transcript T-DM1 - Research To Practice


        	
  • Company
  • Nicosia Constantinou Palaiologou 16, Palouriotissa, 1040
  • +357 64-733-402
  • [email protected]
  • Links
  • About
  • Contact
  • Help / FAQ
  • Legal
  • Terms of Service
  • Privacy policy
  • Cookie policy
  • Disclaimer

slideum.com © 2026, Inc. All rights reserved.

Directory